A recent study from Finland reports that a protein kinase called LRRK2 is hyperactive in skin samples from Parkinson’s disease patients which leads to a decrease in protein synthesis.
New agreement signed with i2020 to tackle neurological diseases
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
Turku Bioscience research groups successful in receiving funding from The Health from Science (TERVA) Academy Programme follow-up call
The Health from Science (TERVA) Academy Programme seeks bold, new research initiatives that can solve health issues related to major public health diseases. The programme highlights the importance of scientific…
Frontiers of Science: 2012 Nobel Laureate Brian K. Kobilka
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
Researchers Develop a Simplified Method to Modify Disease Signaling with Light
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
CIC: Olympus VS200 Slide Scanner Demo
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
Atomic Force Microscopy: Describing the mechanical properties of diverse materials
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
Frontiers of Science: Reprogramming T Cells with CRISPR
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
Frontiers of Science: Why are diseases tissue-specific? Lessons from mitochondrial diseases
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…
Turku Bioscience research groups receiving significant funding for 2020–2023 from the Flagship Programme of the Academy of Finland
Parkinson’s Patient Skin Samples Provide Clues to Disease Mechanism and a Possible Clinical Test…